NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹258 Cr | ₹218 Cr | ₹199 Cr | ₹150 Cr | ₹9,494,069 Cr |
What is the latest Appropriations of NGL FINECHEM ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹218 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹150 Cr |
| Mar2021 | ₹9,494,069 Cr |
How is Appropriations of NGL FINECHEM Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 18.36 | |
| Mar2024 | ₹218 Cr | 9.71 | |
| Mar2023 | ₹199 Cr | 32.45 | |
| Mar2022 | ₹150 Cr | -100.00 | |
| Mar2021 | ₹9,494,069 Cr | - | |
Compare Appropriations of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,977.3 Cr | -1.3% | 13.5% | 169% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.3% |
13.5% |
169% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses